Abatacept
Brand name: Orencia
Rank #87 of 500 drugs by total cost
$216.6M
Total Cost
36,753
Total Claims
$216.6M
Total Cost
1,504
Prescribers
$5,892
Cost per Claim
669
Beneficiaries
38,797
30-Day Fills
$144K
Avg Cost/Provider
24
Avg Claims/Provider
About Abatacept
Abatacept (sold as Orencia) was prescribed 36,753 times by 1,504 Medicare Part D providers in 2023, costing the program $216.6M. At $5,892 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 84 | Pimavanserin Tartrate (Nuplazid) | $219.0M | 51,053 |
| 85 | Metformin Hcl (Metformin Hcl) | $218.8M | 14,222,346 |
| 86 | Diclofenac Sodium (Diclofenac Sodium) | $216.8M | 3,418,852 |
| 87 | Abatacept (Orencia) | $216.6M | 36,753 |
| 88 | Losartan Potassium (Losartan Potassium) | $213.4M | 14,466,748 |
| 89 | Oxycodone Hcl (Oxycodone Hcl) | $213.2M | 3,537,078 |
| 90 | Brexpiprazole (Rexulti) | $204.0M | 136,378 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology